PLAA Activators refers to a category of chemicals specifically tailored to enhance the expression or functionality of the Phospholipase A2-Activating Protein (PLAA). These molecules are intricately designed to interact with various biological pathways and processes to augment the presence and activity of PLAA within cellular systems. Some activators operate at the genetic level, modulating transcriptional activity. For instance, compounds like histone deacetylase inhibitors and DNA methyltransferase inhibitors work meticulously by altering chromatin configurations and DNA methylation landscapes. These modifications foster an environment conducive to the robust transcription of the PLAA gene, thereby bolstering its expression and presence within cells.
Furthermore, the realm of PLAA Activators is broadened by the inclusion of molecules that influence protein stability, such as proteasome inhibitors. These particular activators work by hindering the degradation of the PLAA protein, ensuring its persistence and sustained activity within cellular mechanisms. Additionally, some activators indirectly influence PLAA by targeting and modulating pivotal cellular signaling pathways and upstream regulatory elements, showcasing the multifaceted approaches in the activation of PLAA. This diversity in mechanisms underlines the complexity and multi-layered regulation of PLAA in cellular biology, underscoring the sophisticated strategies and breadth of scientific understanding utilized in the design and function of PLAA Activators. Through these multi-pronged approaches, PLAA Activators exemplify the intricate and nuanced orchestration of molecular tools in the modulation of specific cellular proteins.
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Valproic Acid | 99-66-1 | sc-213144 | 10 g | $87.00 | 9 | |
Histone deacetylase inhibitor (HDACi) that can promote gene expression by increasing chromatin accessibility. | ||||||
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $152.00 $479.00 $632.00 $1223.00 $2132.00 | 33 | |
Another HDACi that can enhance gene expression by affecting chromatin structure. | ||||||
5-Azacytidine | 320-67-2 | sc-221003 | 500 mg | $280.00 | 4 | |
DNA methyltransferase inhibitor that can alter DNA methylation patterns, potentially leading to increased gene expression. | ||||||
Resveratrol | 501-36-0 | sc-200808 sc-200808A sc-200808B | 100 mg 500 mg 5 g | $80.00 $220.00 $460.00 | 64 | |
Known to modulate various signaling pathways and transcription factors, potentially influencing PLAA expression. | ||||||
Sodium Butyrate | 156-54-7 | sc-202341 sc-202341B sc-202341A sc-202341C | 250 mg 5 g 25 g 500 g | $31.00 $47.00 $84.00 $222.00 | 19 | |
HDACi that can promote gene expression by affecting chromatin accessibility. | ||||||
Retinoic Acid, all trans | 302-79-4 | sc-200898 sc-200898A sc-200898B sc-200898C | 500 mg 5 g 10 g 100 g | $66.00 $325.00 $587.00 $1018.00 | 28 | |
Affects transcription factors and signaling pathways, potentially influencing PLAA gene expression. | ||||||
Dexamethasone | 50-02-2 | sc-29059 sc-29059B sc-29059A | 100 mg 1 g 5 g | $91.00 $139.00 $374.00 | 36 | |
Steroid that can modulate various cellular pathways and transcription factors, potentially influencing PLAA expression. | ||||||
SB 431542 | 301836-41-9 | sc-204265 sc-204265A sc-204265B | 1 mg 10 mg 25 mg | $82.00 $216.00 $416.00 | 48 | |
TGF-beta inhibitor that might influence signaling pathways related to PLAA expression. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
JNK inhibitor that can modulate MAPK signaling, potentially impacting PLAA expression. | ||||||
Y-27632, free base | 146986-50-7 | sc-3536 sc-3536A | 5 mg 50 mg | $186.00 $707.00 | 88 | |
ROCK inhibitor that might influence various signaling pathways related to PLAA expression. | ||||||